Open AccessGemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma
Author(s) -
Mi Mi,
Caijiao Zhang,
Zijian Liu,
Ye Wang,
Juan Li,
Liling Zhang
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000023412
Subject(s) - medicine , ifosfamide , carboplatin , gemcitabine , etoposide , salvage therapy , refractory (planetary science) , gastroenterology , lymphoma , dexamethasone , adverse effect , surgery , oncology , chemotherapy , urology , cisplatin , physics , astrobiology